Top Markets
Coin of the day
Petros Pharmaceuticals, Inc. Petros Pharmaceuticals, Inc.

Petros Pharmaceuticals, Inc.

PTPI
Pozycja w akcjach #40525
Petros Pharmaceuticals, Inc. is a pharmaceutical company dedicated to male... Petros Pharmaceuticals, Inc. is a pharmaceutical company dedicated to male health solutions. Their activities include both the commercialization and ongoing development of Stendra, a prescription PDE-5 inhibitor specifically designed for treating erectile dysfunction (ED). Furthermore, Petros is advancing H100, a proprietary topical formulation currently in development as a potential treatment for acute Peyronie's disease. The company's offerings also extend to a range of erectile dysfunction products, such as vacuum erection devices. Petros Pharmaceuticals, Inc. operates from its base in New York, New York.
Cena akcji
$0.0034
Kapitalizacja rynkowa
$144.07K
Zmiana (1 dzień)
13.33%
Zmiana (1 rok)
-88.67%
Kraj
US
Handel Petros Pharmaceuticals, Inc. (PTPI)

Kategoria

Historia stopy dywidendy dla Petros Pharmaceuticals, Inc. (PTPI)
Stopa dywidendy (TTM) dla Petros Pharmaceuticals, Inc. (symbol akcji: PTPI) na dzień 2026 wynosi: 0
Średnia stopa dywidendy z ostatnich 5 lat: 0.00%
Historia stopy dywidendy dla Petros Pharmaceuticals, Inc. (PTPI) od 2026 do 2026
Stopa dywidendy na koniec każdego roku (TTM)
Rok Stopa dywidendy Zmień
Za mało danych dla podanych dat.
Stopy dywidendy (TTM) dla podobnych firm lub konkurencji